Synthesis and Anti-Angiogenic Activity of Novel c(RGDyK) Peptide-Based JH-VII-139-1 Conjugates

Peptide–drug conjugates are delivery systems for selective delivery of cytotoxic agents to target cancer cells. In this work, the optimized synthesis of JH-VII-139-1 and its c(RGDyK) peptide conjugates is presented. The low nanomolar SRPK1 inhibitor, JH-VII-139-1, which is an analogue of Alectinib,...

Descripción completa

Detalles Bibliográficos
Autores principales: Leonidis, George, Koukiali, Anastasia, Sigala, Ioanna, Tsimaratou, Katerina, Beis, Dimitris, Giannakouros, Thomas, Nikolakaki, Eleni, Sarli, Vasiliki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962512/
https://www.ncbi.nlm.nih.gov/pubmed/36839704
http://dx.doi.org/10.3390/pharmaceutics15020381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962512/
https://www.ncbi.nlm.nih.gov/pubmed/36839704
http://dx.doi.org/10.3390/pharmaceutics15020381

Ejemplares similares